// App-Quantinova.ai

S1004 2015 AHA : Is the Post-menopausal Rise in PCSK9 Levels Due to Loss of the Estrogen Responsive Anti-atherogenic Protein, Heat Shock Protein 27? Insights into a Potential New PCSK9 Lowering Therapy

Researchers

Presenter

  • Chunhua Shi

Principal Investigators

  • Vivek Krishna Pulakazhi Venu

  • Yong-Xiang Chen

  • Edward R O'Brien

Medical Centers

  • Libin Cardiovascular Inst of Alberta / Cumming Sch of Med/ Univ of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Nucleoside diphosphate kinase A

  • Proprotein convertase subtilisin/kexin type 9

  • Heat shock protein 27

  • Translocator protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved